Published receptor-binding analyses position retatrutide as having lower relative GCGR potency than mature glucagon, which is part of its rationale as a balanced research probe (Coskun et al., 2022)
In the context of patients with MASLD and diabetes, only one clinical study evaluated the benefits of beinaglutide treatment over 24 weeks compared to recommended standard lifestyle management for T2DM
Do you need injections
Singapore authorities looking into illegal online sale of weight loss patches, slimming drugs Doctors warned that such products could make people ill or cause serious health complications
Three times weekly dosing on a Monday, Wednesday, Friday schedule reduces peaks by 35% with a peak-to-trough ratio of 1.6
844-857, Subhani, Mohsan, et al